Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
cultivate (MD) is a U.S.-based healthcare venture capital organization focused primarily on early-stage medical device and healthcare technology companies. The firm operates seed, accelerator, and opportunity-style funds and positions itself as a hands-on investor helping portfolio companies progress from development toward commercialization. Its portfolio has included orthopedic, surgical, regenerative medicine, imaging, and healthcare operations businesses, with disclosed exits and public-market outcomes among portfolio companies. While it is healthcare-focused, cultivate (MD) is not a drug-development biotech or pharma operating company; it is an investment platform backing medtech and related healthcare innovators.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on cultivate Accelerator Capital.